TheEdgeResearch
Home / Stocks / BKUH

Bakhu Holdings, Corp. (BKUH)

OTC Healthcare Drug Manufacturers - Specialty & Generic
$0.00 ▲ +0.00%
Market Cap
$301,303
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Beta
2.56
52-Wk Range
0.001-0.5
CEO
Konstantia Galazi
Country
US
Currency
USD

Bakhu Holdings, Corp. operates in the Drug Manufacturers - Specialty & Generic industry of the Healthcare sector, headquartered in Long Beach, CA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $301,303. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of 0.0%. Its beta of 2.56 implies it has historically moved more than the broad market.

Valuation & profitability (TTM)
P/E
-0.03
Price / Sales
0.00
Price / Book
-0.03
EV / EBITDA
-0.71
Gross margin
0.0%
Operating margin
0.0%
Net margin
0.0%
Return on equity
Debt / equity
-0.72
Current ratio
0.00
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2
IPO date
2018-02-13
Headquarters
Long Beach, CA, US
About Bakhu Holdings, Corp.

Headquartered in Long Beach, California, Bakhu Holdings, Corp. was established in 2008. This company specializes in the creation, manufacturing, and sale of cannabis-derived products, catering to medical, food additive, and recreational markets throughout the United States and the Caribbean. It operated as Planet Resources, Corp. until May 2009, when it adopted its current name.

Comparable companies

Bakhu Holdings, Corp. is most often compared with the following Healthcare names:

ACBMAKOMASRECVGRFCZBTSPBBF
More research on BKUH
BKUH technical analysis BKUH TheEdge Score Compare against peers
Open full interactive analysis & DCF →